Literature DB >> 23585345

Reduced diurnal variation of heart rate is associated with increased plasma B-type natriuretic peptide level in patients with atrial fibrillation.

Shigeshi Kamikawa1, Toru Miyoshi, Masayuki Doi, Naoko Orita, Mutsuko Sangawa, Takaaki Nakatsu, Youko Noguchi, Satoshi Hirohata, Shozo Kusachi, Kazufumi Nakamura, Hiroshi Ito.   

Abstract

BACKGROUND: The plasma B-type natriuretic peptide (BNP) level has been shown to be increased in patients with chronic atrial fibrillation (AF) independent of left ventricular ejection fraction (LVEF). The purpose of this study is to evaluate the relationship between the plasma BNP level and heart rate variation in patients with AF. HYPOTHESIS: The plasma BNP level is associated with heart rate variation in patients with AF.
METHODS: A total of 102 patients with AF and preserved LVEF were included from 2 hospitals. The ambulatory electrocardiographic recording and measurement of plasma BNP levels were performed simultaneously. Echo-Doppler parameters were measured as the average of 10 consecutive cardiac cycles.
RESULTS: A difference in the mean heart rate between night and day (DIFF) and the standard deviation of the 5-miniute mean R-R interval (SDARR) were significantly associated with log-transformed BNP levels (r = -0.411, P < 0.001 and r = -0.243, P = 0.049, respectively). In echocardiography, the ratio of E velocity to early diastolic velocity, which reflects left ventricular (LV) filling pressure, was significantly correlated with the DIFF and SDARR, along with the log-transformed BNP level. Stepwise multiple linear regression analysis revealed that the DIFF and age were independent factors related with the BNP level (P < 0.01).
CONCLUSIONS: The reduced diurnal variation of heart rate was significantly associated with increased BNP, which is linked to LV diastolic dysfunction in patients with AF.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23585345      PMCID: PMC6649433          DOI: 10.1002/clc.22128

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  34 in total

1.  Effect of beta-adrenergic blocker therapy on the circadian rhythm of heart rate variability in patients with chronic stable angina pectoris.

Authors:  A J Burger; M Kamalesh
Journal:  Am J Cardiol       Date:  1999-02-15       Impact factor: 2.778

Review 2.  ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).

Authors:  Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Z Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  J Am Soc Echocardiogr       Date:  2003-10       Impact factor: 5.251

3.  Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.

Authors:  R B Devereux; N Reichek
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

4.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.

Authors:  Emily Lubien; Anthony DeMaria; Padma Krishnaswamy; Paul Clopton; Jen Koon; Radmila Kazanegra; Nancy Gardetto; Erin Wanner; Alan S Maisel
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

5.  Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction.

Authors:  S H Poulsen; S E Jensen; J E Møller; K Egstrup
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

6.  Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure.

Authors:  Jiro Koyama; Jun Watanabe; Aki Yamada; Yoshito Koseki; Yuji Konno; Sunao Toda; Tsuyoshi Shinozaki; Masahito Miura; Mitsumasa Fukuchi; Mototsugu Ninomiya; Yutaka Kagaya; Kunio Shirato
Journal:  Circ J       Date:  2002-10       Impact factor: 2.993

7.  Reduced ventricular response irregularity is associated with increased mortality in patients with chronic atrial fibrillation.

Authors:  A Yamada; J Hayano; S Sakata; A Okada; S Mukai; N Ohte; G Kimura
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

8.  Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.

Authors:  A Mortara; M T La Rovere; G D Pinna; R Maestri; S Capomolla; F Cobelli
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

9.  B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.

Authors:  Rudolf Berger; Martin Huelsman; Karin Strecker; Anja Bojic; Petra Moser; Brigitte Stanek; Richard Pacher
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

10.  Relationship between heart rate variability and left ventricular remodeling after reperfused first anterior wall acute myocardial infarction.

Authors:  Yusei Abe; Akira Tamura; Masaru Nasu
Journal:  Circ J       Date:  2003-03       Impact factor: 2.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.